[Federal Register Volume 88, Number 211 (Thursday, November 2, 2023)]
[Notices]
[Pages 75295-75296]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24224]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Center for 
Advancing Translational Sciences Advisory Council.
    This meeting is being held virtually only. The open session will be 
videocast and may be accessed by the public from the NIH Videocasting 
and Podcasting website (http://videocast.nih.gov). Individuals who need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the Contact Person listed 
below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Advisory Council.
    Date: January 18, 2024.
    Closed: 11:00 a.m. to 12:15 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, 9th Floor, 
Conference Room 987/989, 6701 Democracy Boulevard, Bethesda, MD 
20892 (Virtual Meeting).
    Open: 12:30 p.m. to 6:00 p.m.
    Agenda: Report from the Center Director, Program Update(s), 
Clearance of Concept(s), Special Topic presentation.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, 9th Floor, 
Conference Room 987/989, 6701 Democracy Boulevard, Bethesda, MD 
20892 (Virtual Meeting).
    Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive 
Secretary, National Center for Advancing Translational Sciences, One 
Democracy Plaza, Room 1072, Bethesda, MD 20892, (301) 435-0809, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice no later than 15 days after the meeting at 
[email protected]. The statement should include the 
name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles

[[Page 75296]]

will be inspected before being allowed on campus. Visitors attending 
a meeting on campus or at an off-campus federal facility will be 
asked to show one form of identification (for example, a government-
issued photo ID, driver's license, or passport) and to state the 
purpose of their visit.
    (National Center for Advancing Translational Sciences, National 
Institutes of Health, HHS Assistance Listing Number (formerly 
Catalog of Federal Domestic Assistance (CFDA) numbers) No. 93.350.)

    Dated: October 30, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-24224 Filed 11-1-23; 8:45 am]
BILLING CODE 4140-01-P